Market Overview

Analysts Come Out Bullish On Radius Health, Shares Rally

Share:
Related RDUS
Apparently Fake Press Release Roils Radius Health Investors
A Peek Into The Markets: U.S. Stock Futures Edge Higher; Netflix Earnings In Focus
Radius Health Announces that the Committee for Medicinal Products for Human Use (CHMP) Has ... (GuruFocus)

Early Wednesday morning, four analyst firms issued notes initiating bullish coverage on Radius Health (NASDAQ: RDUS).

Shares of Radius Health have shot up nearly six percent on the news. The firms respective ratings and price targets are listed below.

  • Canaccord Genuity - Buy, $21
  • Cowen & Company - Outperform, N/A
  • Cantor Fitzgerald - Buy, $20
  • Jefferies - Buy, $17

The average of these price targets is $19.33, which represents 53 percent upside to last check price of $12.62.

Latest Ratings for RDUS

DateFirmActionFromTo
May 2017Cowen & Co.DowngradesOutperformMarket Perform
Mar 2017H.C. WainwrightReiteratesBuy
May 2016H.C. WainwrightInitiates Coverage onBuy

View More Analyst Ratings for RDUS
View the Latest Analyst Ratings

Posted-In: Canaccord Genuity Cantor FitzgeraldAnalyst Color Price Target Initiation Hot Analyst Ratings Movers

 

Related Articles (RDUS)

View Comments and Join the Discussion!